THURSDAY, Aug. 7, 2025 (HealthDay News) -- A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP
Study IDs Barriers to GLP-1 Receptor Agonist Use in Adolescents, Young Adults
HealthDay08/07
114
The Cut
Raw Story
America News
CNN Health
KSNB Local4 Central Nebraska
The Outer Banks Voice Community
AlterNet
Omak Okanogan County Chronicle
The US Sun Health